Chase Leavitt

Chase Leavitt

General Counsel chez ONCTERNAL THERAPEUTICS, INC.

Fortune : 38 142 $ au 31/03/2024

42 ans
Health Technology
Finance
Consumer Services

Profil

Chase C.
Leavitt
is currently working as the Secretary & General Counsel at Oncternal Therapeutics, Inc. He previously worked as the Secretary & General Counsel at Lineage Cell Therapeutics, Inc. from 2019 to 2021.
Before that, he was the Vice President-Legal Affairs at Tang Capital Management LLC from 2018 to 2019.
From 2007 to 2014, he worked as an Attorney at Latham & Watkins LLP.
He also served as the Deputy General Counsel at Switch, Inc. from 2017 to 2018 and as the Vice President-Legal Affairs at Odonate, Inc. from 2018 to 2019.
Mr. Leavitt completed his undergraduate and graduate degrees at the University of Southern California in 2007.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
14/02/2024 4 238 ( 0,14% ) 38 142 $ 31/03/2024

Postes actifs de Chase Leavitt

Anciens postes connus de Chase Leavitt

SociétésPosteFin
LINEAGE CELL THERAPEUTICS, INC. General Counsel 29/03/2021
ODONATE, INC. General Counsel 01/05/2019
General Counsel 01/05/2019
Corporate Officer/Principal 01/05/2018
Corporate Officer/Principal 01/01/2014
Voir l'expérience en détail de Chase Leavitt

Formation de Chase Leavitt

University of Southern California Graduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Chase Leavitt

Relations

99

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées3
LINEAGE CELL THERAPEUTICS, INC.

Health Technology

ODONATE, INC.

Health Technology

ONCTERNAL THERAPEUTICS, INC.

Health Technology

Entreprise privées3

Finance

Commercial Services

Technology Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Chase Leavitt